全文获取类型
收费全文 | 9652篇 |
免费 | 578篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 177篇 |
妇产科学 | 91篇 |
基础医学 | 1225篇 |
口腔科学 | 211篇 |
临床医学 | 628篇 |
内科学 | 2642篇 |
皮肤病学 | 314篇 |
神经病学 | 542篇 |
特种医学 | 358篇 |
外科学 | 1747篇 |
综合类 | 40篇 |
预防医学 | 195篇 |
眼科学 | 193篇 |
药学 | 603篇 |
中国医学 | 20篇 |
肿瘤学 | 1222篇 |
出版年
2024年 | 11篇 |
2023年 | 145篇 |
2022年 | 268篇 |
2021年 | 415篇 |
2020年 | 225篇 |
2019年 | 319篇 |
2018年 | 383篇 |
2017年 | 283篇 |
2016年 | 303篇 |
2015年 | 291篇 |
2014年 | 379篇 |
2013年 | 414篇 |
2012年 | 716篇 |
2011年 | 683篇 |
2010年 | 393篇 |
2009年 | 332篇 |
2008年 | 555篇 |
2007年 | 642篇 |
2006年 | 575篇 |
2005年 | 580篇 |
2004年 | 561篇 |
2003年 | 497篇 |
2002年 | 490篇 |
2001年 | 74篇 |
2000年 | 70篇 |
1999年 | 91篇 |
1998年 | 96篇 |
1997年 | 75篇 |
1996年 | 72篇 |
1995年 | 52篇 |
1994年 | 50篇 |
1993年 | 43篇 |
1992年 | 33篇 |
1991年 | 33篇 |
1990年 | 24篇 |
1989年 | 19篇 |
1988年 | 20篇 |
1987年 | 13篇 |
1986年 | 6篇 |
1985年 | 10篇 |
1984年 | 8篇 |
1983年 | 9篇 |
1982年 | 19篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1978年 | 3篇 |
1977年 | 6篇 |
1976年 | 2篇 |
1974年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
941.
K Katsumata N Musiake K Shibuya T Nakajima M Watanabe M Sasaki Y Sugiyama 《Oncology letters》2011,2(3):509-514
The anti-tumor effect of a cyclooxygenase (COX)-2 selective inhibitor or a non-specific immunostimulant (PSK) alone, as well as the anti-tumor effect of their combined administration were examined on a hepatic metastasis model of colon cancer using a colon 26 cell line (CT26) and its highly metastatic variant. Anti-tumor effects were assessed by the number of hepatic metastases. Serum MMP-9, TGF-β and IL-6 were also measured. In a preliminary experiment, cells (5×10(5)) of a mouse colon cancer 26 cell line (CT26) and its highly metastatic variant were implanted below the splenic capsule in BALB/c and CDF1 mice. The number of hepatic metastatic CT26 cell lesions in the CDF1 mice of the non-spleen-removed group at 2 weeks was found to be optimum for the experiments. Although no significant difference was found, etodolac treatment showed the highest inhibitory effect on the number of hepatic metastases at a concentration of 30 mg/kg. In contrast, intraperitoneal administration of 50 mg/kg PSK showed an inhibitory effect on hepatic metastases, but a significant difference was not observed. PSK (p=0.002) or the combined use of etodolac and PSK (p=0.001) exhibited a significant inhibition of the number of hepatic metastases. In addition, MMP-9 was significantly inhibited by the single use of etodolac or PSK, and was inhibited with an additive effect by the combined use of etodolac and PSK. IL-6 and TGF-β were significantly inhibited following the combined use of etodolac and PSK. In conclusion, etodolac did not exhibit any significant hepatic metastasis inhibitory effect, whereas it significantly reduced the MMP-9 level. PSK reduced both the number of hepatic metastases and MMP-9. Combined use of etodolac and PSK did not show any additive effect in the inhibition of the number of hepatic metastases, whereas it inhibited MMP-9, TGF-β and IL-6, suggesting the benefit of a combined effect. 相似文献
942.
Najmuldeen IA Hadi AH Awang K Mohamad K Ketuly KA Mukhtar MR Chong SL Chan G Nafiah MA Weng NS Shirota O Hosoya T Nugroho AE Morita H 《Journal of natural products》2011,74(5):1313-1317
Three new limonoids, chisomicines A-C (1-3), have been isolated from the bark of Chisocheton ceramicus. Their structures were determined by 2D NMR, CD spectroscopic methods, and X-ray analysis. Chisomicine A (1) exhibited NO production inhibitory activity in J774.1 cells stimulated by LPS dose-dependently at high cell viability. 相似文献
943.
944.
Horinouchi T Terada K Higa T Aoyagi H Nishiya T Suzuki H Miwa S 《Journal of pharmacological sciences》2011,117(4):295-306
The purpose of this study is to identify transient receptor potential canonical (TRPC) channels responsible for receptor-operated Ca(2+) entry (ROCE) triggered by activation of endothelin type A receptor (ET(A)R) and to clarify the importance of calmodulin (CaM) / inositol 1,4,5-trisphosphate (IP(3)) receptor binding (CIRB) domain at the C terminus of TRPC channels in ET(A)R-activated channel regulation. In HEK293 cells coexpressing ET(A)R and one of seven TRPC isoforms, ET(A)R stimulation induced ROCE through TRPC3, TRPC5, TRPC6, and TRPC7. The TRPC3- and TRPC6-mediated ROCE was inhibited by selective inhibitors of G(q) protein, phospholipase C (PLC), and CaM. The CIRB domain deletion mutants of TRPC3 and TRPC6 failed to induce ET(A)R-mediated ROCE. Either deletion of the CIRB domain or pharmacological inhibition of CaM did not inhibit the targeting of these channels to the plasma membrane. These results suggest that 1) TRPC3, TRPC5, TRPC6, and TRPC7 can function as ET(A)R-operated Ca(2+) channels; 2) G(q) protein, PLC, and CaM are involved in TRPC3- and TRPC6-mediated ROCE; 3) ET(A)R-mediated activation of TRPC3 and TRPC6 requires the CIRB domain; and 4) abolition of ET(A)R-induced ROCE by CIRB domain deletion and CaM inhibition is due to loss of CaM binding to the channels but not loss of cell surface TRPC3 and TRPC6. 相似文献
945.
Sakai K Miyahara T Tsutsumi K Kaneko T Fukushima M Tanaka Y Hongo K 《Brain tumor pathology》2011,28(2):151-156
We present a case of spontaneous regression of multicentric pilocytic astrocytoma with cerebrospinal fluid (CSF) dissemination
without neurofibromatosis type 1 (NF1) in an adult, the first such case reported. Magnetic resonance imaging (MRI) showed
multiple low signal intensity lesions on T1-weighted images and high signal intensity areas on T2-weighted images in the bilateral
thalamus, basal ganglia and midbrain. Contrast-enhanced MRI revealed that small, enhanced lesions were seen in the basal ganglia
and the pineal region. Neuroendoscopic biopsy and third ventriculostomy were performed. Intraoperative findings demonstrated
CSF dissemination. Histologically, the specimens showed pilocytic astrocytoma. Serial MRIs showed regression of the tumor
without any additional treatment. The clinical features of spontaneous regression of pilocytic astrocytoma are discussed. 相似文献
946.
Nakajima T Yasufuku K Suzuki M Hiroshima K Nakatani Y Fujisawa T Yoshino I 《Clinical lung cancer》2011,12(5):293-297
947.
Tadahiro Nozoe Emiko Mori Tomohiro Iguchi Akinori Egashira Eisuke Adachi Akito Matsukuma Takahiro Ezaki 《Breast cancer (Tokyo, Japan)》2011,18(1):37-41
Background
Molecular-targeting drugs able to treat breast cancer expressing epidermal growth factor receptor (EGFR) would be clinically valuable. The aim of the current study was to determine the further significance of immunohistochemical expression of EGFR in breast cancer. 相似文献948.
Seo S Nakamoto T Takeshita M Lu J Sato T Suzuki T Kamikubo Y Ichikawa M Noda M Ogawa S Honda H Oda H Kurokawa M 《Cancer science》2011,102(12):2109-2117
The p210Bcr/Abl and p190Bcr/Abl fusion oncoproteins are known to cause chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Bcr/Abl phosphorylates several proteins that can lead to leukemogenesis. Crk-associated substrate lymphocyte type (Cas-L)/human enhancer of filamentation-1 (HEF1)/neural precursor cell expressed, developmentally down-regulated 9 (NEDD9) is an adapter protein at focal adhesions known to be associated with solid tumor metastasis. Crk-associated substrate lymphocyte type has also been reported to be tyrosine phosphorylated by p190Bcr/Abl. We demonstrated that Cas-L was expressed in murine granulocytes, as well as in lymphocytes, and that Cas-L-deficient (Cas-L(-/-) ) granulocytes had increased migratory activity and decreased adhesiveness. To examine whether Cas-L was involved in leukemogenesis by p210Bcr/Abl, we generated Cas-L(-/-) p210Bcr/Abl transgenic mice. The mice displayed early development of myeloproliferative neoplasm seen in the chronic phase of CML, which resulted in the early death of the mice. Pathologically, increased infiltration of myeloid cells into several tissues was detected in the absence of Cas-L. In a hematopoietic reconstitution assay, Cas-L(-/-) p210Bcr/Abl transgenic cells showed a low population in the spleen, although only their myeloid cell population was normal. Thus, Cas-L seems to regulate the progression of CML in a negative way, presumably by attenuating extramedullary hyperplasia. 相似文献
949.
950.
Anu Gupta Srirupa Roy Alexander J. F. Lazar Wei-Lien Wang John C. McAuliffe David Reynoso James McMahon Takahiro Taguchi Giuseppe Floris Maria Debiec-Rychter Patrick Sch?ffski Jonathan A. Trent Jayanta Debnath Brian P. Rubin 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(32):14333-14338
Although gastrointestinal stromal tumors (GISTs) harboring activating KIT or platelet-derived growth factor receptor A (PDGFRA) mutations respond to treatment with targeted KIT/PDGFRA inhibitors such as imatinib mesylate, these treatments are rarely curative. Most often, a sizeable tumor cell subpopulation survives and remains quiescent for years, eventually resulting in acquired resistance and treatment failure. Here, we report that imatinib induces autophagy as a survival pathway in quiescent GIST cells. Inhibiting autophagy, using RNAi-mediated silencing of autophagy regulators (ATGs) or antimalarial lysosomotrophic agents, promotes the death of GIST cells both in vitro and in vivo. Thus, combining imatinib with autophagy inhibition represents a potentially valuable strategy to promote GIST cytotoxicity and to diminish both cellular quiescence and acquired resistance in GIST patients. 相似文献